Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1-Reference-Cited by-同舟云学术

Rituximab for reduction of anti-HLA antibodies in patients awaiting renal transplantation: 1. Safety, pharmacodynamics, and pharmacokinetics1

Published:2004-02 Issue:4 Volume:77 Page:542-548
ISSN:0041-1337
Container-title:Transplantation
language:en
Short-container-title:Transplantation

Author:

Vieira Carlos A.,Agarwal Avinash,Book Benita K.,Sidner Richard A.,Bearden Christopher M.,Gebel Howard M.,Roggero Anthony L.,Fineberg Naomi S.,Taber Timothy,Kraus Michael A.,Pescovitz Mark D.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Transplantation

Reference29 articles.

1. Flow-PRA evaluation for antibody screening in patients awaiting kidney transplantation

2. SENSITIZATION AND SENSITIVITY

3. INTRAVENOUS IMMUNOGLOBULIN SUPPRESSION OF HLA ALLOANTIBODY IN HIGHLY SENSITIZED TRANSPLANT CANDIDATES AND TRANSPLANTATION WITH A HISTOINCOMPATIBLE ORGAN

4. POSTTRANSPLANT THERAPY USING HIGH-DOSE HUMAN IMMUNOGLOBULIN (INTRAVENOUS GAMMAGLOBULIN) TO CONTROL ACUTE HUMORAL REJECTION IN RENAL AND CARDIAC ALLOGRAFT RECIPIENTS AND POTENTIAL MECHANISM OF ACTION1

5. SUPPRESSION OF HLA-SPECIFIC ALLOANTIBODIES BY HIGH-DOSE INTRAVENOUS IMMUNOGLOBULINS (IVIg)

Cited by 241 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. B-Cell Induction Therapies in Intestinal Transplantation;Gastroenterology Clinics of North America;2024-09

2. Effect of Induction Therapy Dose on Survival in Abo-Incompatible Kidney Transplantation: A Network Meta-Analysis Using Recent Data;Transplantation Proceedings;2024-04

3. Modern advances in heart transplantation;Progress in Cardiovascular Diseases;2024-01

4. Kidney transplantation: the recipient;Living Donor Organ Transplantation;2024

5. Anti-CD20 antibodies in glomerular diseases, their resistance and reversal approaches;Resistance to Anti-Cd20 Antibodies and Approaches for their Reversal;2024